Jumpcode Genomics and TGen collaborate on genomic sequencing of SARS-CoV-2

By | September 14, 2021
Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today a collaboration with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, to aid investigations into the genomic epidemiology of SARS-CoV-2, the virus that causes COVID-19.